Keynote speakers

Professor Theresa Wiseman

Professor Theresa Wiseman holds a clinical chair of Supportive Cancer Care between The Royal Marsden NHS Foundation Trust and the University of Southampton. She has over 20 years’ applied health research experience focused on the patient (and carer) experience of cancer and treatment, and developing services and interventions in response to this experience. She is passionate about clinical health service research but more so that the findings are translated into practice and make a difference to patient care

Theresa has expertise in mixed methods research, ethnography and experience based co-design (EBCD) methodologies. She has recently completely a multi-centred study exploring the experience of patients and carers of immunotherapy, developing supportive care guidance. Phase 1 was a qualitative study exploring patient and carer experience. Phase 2 used a Delphi Technique of experts (patients/carers/Clinical Nurse Specialist, oncologists, specialist Applied Health Professionals)  to develop supportive care guidance. Current research includes Safe space – using EBCD to design a Virtual Reality intervention for patients whilst they are having treatment; and a Global Challenge Research Fund project developing survivorship care in Africa (Tanzania & Ghana).

Theresa is a Board Member (secretary) of EONS and a member Research Working Group. She is an international member of the Australian and New Zealand Urology Research Group (ANZUP). Nationally, she is a member of the UK Consequence of Cancer and Treatment Collaborative (CCAT).

Presentation title (Thursday): Partnering to optimise care that matters
Presentation title (Friday): Partnering to optimise outcomes for all

Professor Bernard Rachet

Professor Bernard Rachet qualified in medicine at the University of Saint-Etienne, France and worked as a clinician before entering epidemiological research. He completed an MSc in epidemiology in Paris and a PhD in epidemiology at the International Agency for Research on Cancer (IARC), Lyon, France. Before joining the School in July 2002, he spent three years as a postdoctoral fellow in Montréal (Canada) in the Epidemiology and Biostatistics Unit of Institut National de la Recherche Scientifique – Institut Armand-Frappier. He worked mainly on cancer risks associated with occupational and environmental exposures, and on developments in methodology.

Bernard’s current research is centred on cancer survival, as co-principal investigator (with Michel Coleman) in two successive five-year Cancer Research UK Programme Grants (2005-2015). This involves carrying out a wide range of projects to quantify, describe and explain patterns and trends in cancer survival by socio-economic group, geographic area and ethnicity, as well as extending the methodology and tools for survival analysis, in collaboration with many research partners in the UK and around the world.

Presentation title: Inequalities in cancer care and outcomes, a fatality?

Professor Gail Garvey

Professor Gail Garvey, a Kamilaroi woman from NSW is currently Senior Principal Research Fellow and Deputy Division Leader, Wellbeing and Preventable Chronic Diseases Division, Menzies School of Health Research. Her PhD thesis titled “Psychosocial aspects of cancer care for Indigenous Australians” addresses a critically important aspect of cancer care. 

Prof Garvey has experience and expertise in leading successful national research programs such as the National Centre of Research Excellence in Discovering Indigenous Strategies to Improve Cancer Outcomes via Engagement, Research Translation and Training (NHMRC #1041111 2012-2017) and a Cancer Council NSW funded Strategic Research Partnership (#SRP13-01 2012-2017) both aimed at improving cancer control for Indigenous Australians. Prof Garvey leads work in psychosocial aspects of cancer care for Indigenous Australians. For example, she developed and validated a new tool to measure the unmet support needs of Indigenous cancer patients and is currently translating this tool in cancer centres across Australia; and is conducting a study to understand and measure the relevant dimensions of quality of life for Indigenous people, which is important for developing/evaluating health interventions.

Presentation title: Improving cancer outcomes and experiences of care for Aboriginal and Torres Strait Islander people and their communities

Dr Lisa Briggs

Dr Lisa Briggs is a wife & mother of 2 young children. She has been living with Stage IV lung cancer for 4.5yrs & prior to this run her own sports medicine business as an Osteopath & Exercise Physiologist. Following her diagnosis, she co-wrote a book on positive mental training & now spends her time working as a passionate lung cancer patient advocate. She hopes to be a voice which paves the way for others in the future, & leads to improved outcomes in years to come.

Presentation title: A patient’s perspective: riding the highs & lows of lung cancer care

Charlotte Rush

Charlotte is an Organisational Psychologist and Innovation Consultant at Inventium. Charlotte is passionate about how the science of psychology can create organisations where innovation thrives. Charlotte has a wealth of experience working with clients across industries such as legal, property, FMCG and the public sector in shaping organisational-wide innovation programs and has worked across Asia, the United States, and Australia turning people into innovation dynamos.

Presentation title: Innovation survivor: how to outwit, outthink, and outlast

Professor David Kissane

Professor David W. Kissane, AC, MD is an academic psychiatrist, psycho-oncology researcher and palliative care physician. He is currently the Head of Psychiatry for Monash University in Australia, previously the Chairman of the Department of Psychiatry and Behavioral Sciences at Memorial Sloan-Kettering Cancer Center in New York and, before that, the Foundation Chair of Palliative Medicine at the University of Melbourne. Professor Kissane consults clinically at Cabrini Health and Monash Health.
His academic interests include individual, group, couples and family psychotherapy trials, communication skills training, studies of existential distress, and the ethics of end-of-life care. He developed a cognitive-existential model of group therapy for women with early-stage breast cancer, which ameliorated fear of recurrence, and his trial of supportive-expressive group therapy for advanced breast cancer showed the prevention of depression alongside the improved quality of life. He is best known for his model of family therapy delivered to ‘at risk’ families during palliative care, which prevents complicated grief and depression in bereavement.

Prof Kissane is the author of over 350 publications. He was awarded the Jimmie C. Holland Chair in Psycho-oncology at MSKCC (2008), the Arthur Sutherland Award for lifetime achievement by the International Psycho-Oncology Society (2008), and the Klerman Award for Psychotherapy Research by Cornell University (2012). In 2018, Prof Kissane was made a Companion of the Order of Australia (AC) “for eminent service to psychiatry, particularly psycho-oncology and palliative medicine, as an educator, researcher, author and clinician, and through executive roles with a range of national and international professional medical bodies.” This significant honour recognises his lifetime commitment to improving the psychological well-being of people affected by cancer.

Presentation title: Collaborative care Model to expand services for patients with cancer related depression

Supported by


Conference Managers

Arinex Pty Ltd
ABN 28 000 386 676
91-97 Islington St
Collingwood, VIC 3066
Ph: +61 3 8888 9500



Victorian Tumor Summit 

Victorian Tumour Summits are clinician-led forums that identify unwarranted variations in clinical practice and cancer outcomes that could be addressed through state-wide action.

Mr Paul Cashin will be presenting audit data and outcomes from the Victorian Oesophagogastric Summit with a focus on  multi-disciplinary care, timeliness of care and variations in care.

Dr Belinda Lee will present data and outcomes from the Victorian Pancreatic Summit with a focus on access to multi-disciplinary treatment planning, adjuvant treatment and palliative care referral.

Professor Paul Cashin

Associate Professor Paul Cashin graduated from Monash University in 1984, and trained in General Surgery at the Repatriation General Hospital, Heidelberg, graduating with his Fellowship of the Royal Australasian College of Surgeons (FRACS) in January 1997. He underwent post Fellowship training as an Upper Gastrointestinal Surgeon in the United Kingdom and Monash Health.

Paul is currently the Service Director of General Surgery at Monash Health, Senior Upper Gastrointestinal Surgeon at Monash Health and Director of Medical Services at Jessie McPherson Private Hospital. He is also Adjunct Clinical Associate Professor of Surgery in the Dept. of Surgery, Southern Clinical School, Monash University.

He practices as an Upper GI Surgeon and General Surgeon in both public and private. He has particular sub specialty interests in oesophago-gastric cancer, reflux disease, hiatal hernia and oesophageal motility disorders. He also has a broad interest in General Surgery including gallbladder surgery and abdominal wall hernia surgery. Paul practices his private surgery at Jessie McPherson Private Hospital and The Valley Private Hospital.

Paul is an elected Member of the National Board of the Australian and New Zealand Oesophago-Gastric Surgery Association. He sits on a number of State and Monash Health committees related to oesophago-gastric cancer management, data registries and innovation and care delivery in surgery. He was co-Convenor of the 2016 GSA Annual Scientific Meeting. He is currently an Executive Lead at Monash Health with the Institute for Healthcare Improvement. He Chairs the National Standards Accreditation Committee -Standard 5 (Comprehensive Care). He is a member of ANZGOSA, GSA, ISDE, UEGS, MUGS and AUGIS.

His research interests include common bile duct stones and their management, oesophageal, gastric and pancreatic cancer, acute surgery delivery and Optimal Cancer Care Pathways in Oesophago-gastric Cancer. He has co-written and published many scientific articles on these subjects and written book chapters in two textbooks of General Surgery.

Paul plays an active role in Medical Student teaching and Registrar training.

Click here to read Prof Paul Cashin article on a ‘clinician perspective’

Dr Belinda Lee

Dr Belinda Lee is a Consultant Medical Oncologist at The Northern Hospital. She is also the Philip Hemstritch Centenary Research Fellow at the Walter & Eliza Hall Institute of Medical Research (WEHI).

Belinda leads the pancreatic cancer initiative PURPLE (Pancreatic cancer –Understanding Routine Practice & Lifting End results). This is an Australian wide pancreatic cancer translational registry incorporating research in clinical data with translational efforts in circulating tumour DNA (ctDNA), genomic profiling, inflammation research and pancreatic organoids. Belinda is the study lead Investigator for the DYNAMIC-Pancreas Clinical Trial. This is a multicentre randomised study investigating the role of circulating tumour DNA analysis to inform the adjuvant chemotherapy management in early stage pancreatic cancer.

She is an active member of the Victorian Pancreatic Cancer Summit Working Group and the Biogrid Scientific review panel. She is also a long-standing member of the American Society of Clinical Oncology (ASCO), Medical Oncology Group of Australia (MOGA) as well as the Young Oncologist Group of Australia (YOGA).   

Click here to view the Pancreatic Cancer 2017 Summit featuring Dr Belinda Lee